Aurora Daljit Singh reported option exercise involving 1,424 derivative units of Neumora Therapeutics, Inc. at $0.00 for $0 on Aug 17, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
See Remarks
See Remarks
Filed Aug 19, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
1,424Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
70,797Direct
Trade date
Aug 17, 2026Option exercise
Filed
Aug 19, 2026, 7:17 PM ET2-day reporting delay
Accession
0001610717-26-000362Code M · Transaction 12181
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Aug 17, 2026Sell57,670$1.51−$86,822.19Trade 12165
Aug 17, 2026Sell34,020$1.49−$50,529.91Trade 12166
Aug 17, 2026Sell55,016$1.50−$82,782.58Trade 12169
Aug 18, 2026Sell34,162$1.58−$54,136.52Trade 12171
Aug 18, 2026Sell34,987$1.59−$55,485.88Trade 12173
Aug 19, 2026Sell31,000$1.65−$51,029.10Trade 12176
Aug 19, 2026Sell30,918$1.65−$50,887.94Trade 12178
Aug 17, 2026Option exercise40,890$0.72$29,440.80Trade 12161
Aug 17, 2026Option exercise15,355$0.72$11,055.60Trade 12162
Aug 17, 2026Option exercise1,424$0.72$1,025.28Trade 12163
Aug 17, 2026Option exercise1$0.72$0.72Trade 12164
Aug 17, 2026Option exercise25,279$0.72$18,200.88Trade 12167
Aug 17, 2026Option exercise29,737$0.72$21,410.64Trade 12168
Aug 18, 2026Option exercise34,162$0.72$24,596.64Trade 12170
Aug 18, 2026Option exercise34,987$0.72$25,190.64Trade 12172
Aug 19, 2026Option exercise13,268$0.72$9,552.96Trade 12174
Aug 19, 2026Option exercise17,732$0.72$12,767.04Trade 12175
Aug 19, 2026Option exercise30,918$0.72$22,260.96Trade 12177
Aug 17, 2026Option exercise40,890$0.00$0Trade 12179
Aug 17, 2026Option exercise15,355$0.00$0Trade 12180
Aug 17, 2026Option exercise1$0.00$0Trade 12182
Aug 17, 2026Option exercise25,279$0.00$0Trade 12183
Aug 17, 2026Option exercise29,737$0.00$0Trade 12184
Aug 18, 2026Option exercise34,162$0.00$0Trade 12185
Aug 18, 2026Option exercise34,987$0.00$0Trade 12186
Aug 19, 2026Option exercise13,268$0.00$0Trade 12187
Aug 19, 2026Option exercise17,732$0.00$0Trade 12188
Aug 19, 2026Option exercise30,918$0.00$0Trade 12189
29 transaction rows in this filing. Joint filers share the same rows.

NMRA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
NMRA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −1.8%1w ago −1.2%1d ago −2.4%
Returns since7d −4.9%30d −55%90d180d1y

Footnotes in full

F1: This transaction was executed in multiple trades at prices ranging from $1.46 to $1.555, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F2: This transaction was executed in multiple trades at prices ranging from $1.46 to $1.5277, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3: Shares held by Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries. F4: This transaction was executed in multiple trades at prices ranging from $1.46 to $1.555, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F5: The stock option is fully vested and exercisable. F6: 25% of the shares subject to the option vest on the first anniversary measured from February 1, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. F7: 25% of the shares subject to the option vest on the first anniversary measured from June 30, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. F8: 25% of the shares subject to the option vest on the first anniversary measured from February 13, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. F9: This transaction was executed in multiple trades at prices ranging from $1.49 to $1.645, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F10: This transaction was executed in multiple trades at prices ranging from $1.48 to $1.65, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F11: This transaction was executed in multiple trades at prices ranging from $1.62 to $1.6995, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F12: This transaction was executed in multiple trades at prices ranging from $1.62 to $1.7006, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F13: 25% of the shares subject to the option vest on the first anniversary measured from February 14, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.